The Growing Problem of Multidrug-Resistant Tuberculosis in North Korea
article has not abstract
Vyšlo v časopise:
The Growing Problem of Multidrug-Resistant Tuberculosis in North Korea. PLoS Med 10(7): e32767. doi:10.1371/journal.pmed.1001486
Kategorie:
Policy Forum
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001486
Souhrn
article has not abstract
Zdroje
1. World Health Organization (2012) Global tuberculosis control 2012 (WHO/HTM/TB/2012.6). Geneva: World Health Organization.
2. Food and Agriculture Organization/World Food Program (2011) Crop and food security assessment mission to the Democratic People's Republic of Korea, 25 November 2011. Available: http://www.fao.org/docrep/014/al982e/al982e00.htm. Accessed 15 February 2013.
3. WHO Regional Office for South-east Asia (2009) WHO Country Cooperation Strategy: Democratic People's Republic of Korea: 2009–2013. Available: http://www.who.int/countryfocus/cooperation_strategy/ccs_prk_en.pdf. Accessed 15 Feb 2013.
4. MatiruR, RyanT (2007) The Global Drug Facility: a unique, holistic and pioneering approach to drug procurement and management. Bull World Health Organ 85: 348–353.
5. Tuberculosis in DPR Korea. Available: http://www.dprk.searo.who.int/EN/Section16_55.htm. Accessed 15 February 2013.
6. LewW, PaiM, OxladeO, MartinD, MenziesD (2008) Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med 149: 123–134.
7. World Health Organization (2010) Multidrug and extensively drug resistant tuberculosis (M/XDR-TB): 2010 global report on surveillance and response (WHO/HTM/TB/2010.3). Geneva: World Health Organization.
8. FarmerP (1999) Managerial successes, clinical failures. Int J Tuberc Lung Dis 3: 365–367.
9. MiglioriGB, EspinalM, DanilovaID, PungaVV, GrzemskaM, et al. (2002) Frequency of recurrence among MDR-TB cases ‘successfully’ treated with standardized short-course chemotherapy. Int J Tuberc Lung Dis 6: 858–864.
10. Eugene Bell Foundation. Available: http://www.eugenebell.org. Accessed 15 February 2013.
11. Korea (Democratic Peoples Republic): Strengthening Tuberculosis Control in DPR Korea. Available: http://portfolio.theglobalfund.org/en/Grant/Index?grantNumber=PRK-810-G02-T. Accessed 15 February 2013.
12. ParryJ (2010) North Korea's fight against tuberculosis gets a boost. BMJ 340: c2223.
13. PerryS, LintonH, SchoolnikG (2011) Tuberculosis in North Korea. Science 331: 263.
14. SeungKJ (2010) Does my patient have multidrug-resistant tuberculosis? Clin Infect Dis 51: 379–80.
15. SeungKJ, GelmanovaIE, PeremitinGG, GolubchikovaVT, PavlovaVE, et al. (2004) The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis. Clin Infect Dis 39: 1321–1328.
16. CoxHS, NiemannS, IsmailovG, DoshetovD, OrozcoJD, et al. (2007) Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance. Clin Infect Dis 44: 1421–1427.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2013 Číslo 7
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Changes in Association between Previous Therapeutic Abortion and Preterm Birth in Scotland, 1980 to 2008: A Historical Cohort Study
- Multiplex Identification of Gram-Positive Bacteria and Resistance Determinants Directly from Positive Blood Culture Broths: Evaluation of an Automated Microarray-Based Nucleic Acid Test
- Combatting Substandard and Falsified Medicines: A View from Rwanda
- Reflections on the Global Burden of Disease 2010 Estimates